Brochure | January 26, 2023

Driving Simulation

Source: Altasciences
GettyImages-1364220293 driving

We partnered with CRC to establish lack of driving impairment after nighttime dosing of flibanserin in premenopausal women. The study, sponsored by Sprout Pharmaceuticals, was described as “reassuring” by the FDA.

Accurate driving performance data comparable in sensitivity to over-the-road testing, with:

  • Faster study startup
  • Lower cost
  • No risk of property damage
  • No risk of injuries

The CRC driving simulator has proven sensitivity to the effects of:

  • Age
  • Trauma
  • Neurological disease
  • Drowsiness
  • CNS depressants
  • CNS stimulants
access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader